Clinical Trial Update: Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating bronchoprotective effects of salbutamol in asthma and COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Salbutamol (salbutamol)

Snippet

Sponsor: University of Saskatchewan | Conditions: Asthma, COPD | Phase 4 | Status: COMPLETED